4//SEC Filing
Meek David D. 4
Accession 0001214659-23-000810
CIK 0001576263other
Filed
Jan 18, 7:00 PM ET
Accepted
Jan 19, 9:45 AM ET
Size
4.7 KB
Accession
0001214659-23-000810
Insider Transaction Report
Form 4
Meek David D.
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2023-01-17$42.38/sh−3,179$134,715→ 61,792 total
Footnotes (1)
- [F1]Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the restricted stock units (RSUs) granted on January 14, 2022.
Documents
Issuer
Mirati Therapeutics, Inc.
CIK 0001576263
Entity typeother
Related Parties
1- filerCIK 0001555337
Filing Metadata
- Form type
- 4
- Filed
- Jan 18, 7:00 PM ET
- Accepted
- Jan 19, 9:45 AM ET
- Size
- 4.7 KB